Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: SCORE Intervention.
- Who it may be relevant to
- Registry conditions: Leukemia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Spiritual Care to Optimize Relationships and Experience in Adults With Acute Leukemia (SCORE Trial)
Overview
This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.
Interventions
- Behavioral SCORE Intervention
Participants assigned to this arm will receive regularly scheduled visits from the study spiritual care team during their hospital admission (four times within 14 days).
Primary outcome measures
- Is it feasible to enroll patients to a spiritual intervention study? [Time frame: End of study (approximately 2 years)]
- Will patients accept using the study specific spiritual intervention? [Time frame: End of study (approximately 2 years)]
Secondary outcome measures (3)
- Improvement on Patient Reported Spiritual Wellness [Time frame: End of study (approximately 2 years)]
- Improvement on Patient Reported Quality of Life [Time frame: End of study (approximately 2 years)]
- Improvement on Patient Reported Mood [Time frame: End of study (approximately 2 years)]
Eligibility criteria
Inclusion criteria
- Adults (18 years or older)
- Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy
- Ability to read, understand, and speak the English language
- Ability to understand and the willingness to sign a written informed consent document
Exclusion criteria
- Unable to comply with spiritual care intervention
- Relapsed or refractory acute leukemia
- Cognitive deficits that limit participation and survey questionnaire completion
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- UChicago Medicine Comprehensive Cancer Center — Chicago
Identifiers
NCT: NCT07405424 · IRB25-0210